Is fibrinogen concentrate useful for bleeding in high-risk cardiac surgery? In a study conducted in The Netherlands, [1] 647 patients (from 2011 to 2015) scheduled to have high-risk cardiac surgery ...
Fibrinogen, a soluble plasma glycoprotein and central mediator of haemostasis, exerts diverse functions in cardiovascular pathology. Beyond its canonical role in clot formation, dynamic variations in ...
The top panel, designed with BioRender.com, illustrates the process of clot formation and lysis, beginning with platelet aggregation and activation of the coagulation cascade, followed by the ...
The University of Colorado Anschutz Medical Campus will lead a groundbreaking national clinical trial-supported by a $29 million grant from Octapharma-to evaluate whether early replacement of ...
Before soluble fibrinogen, a blood plasma protein, is converted into insoluble fibrin molecules that can toxically accumulate outside blood vessels in the brain, fibrinogen connects directly with ...
Utilization and cancer detection by U.S. prostate biopsies (2005-2011). Clinical outcome (CO) and predictive factors (PRE) evaluation of a cohort of castration resistant prostate cancer (CRPC) ...
Fesilty is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Fesilty ™ (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results